An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management

BACKGROUND: The World Health Organization’s strategy to halve snakebite mortality and morbidity by 2030 includes an emphasis on a risk-benefit process assessing the preclinical efficacy of antivenoms manufactured for sub-Saharan Africa. To assist this process, we systematically collected, standardis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ainsworth, Stuart, Menzies, Stefanie K., Casewell, Nicholas R., Harrison, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462309/
https://www.ncbi.nlm.nih.gov/pubmed/32817682
http://dx.doi.org/10.1371/journal.pntd.0008579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462309/
https://www.ncbi.nlm.nih.gov/pubmed/32817682
http://dx.doi.org/10.1371/journal.pntd.0008579

Ejemplares similares